Twin Securities »

Apellis Pharmaceuticals shares owned by Twin Securities

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Twin Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 127k 40.23

More positions owned by Twin Securities

Electronic Arts (EA)
Warner Bros Discovery Com Ser A (WBD)
Clearwater Analytics Hldgs I Cl A (CWAN)
Hologic
Kenvue (KVUE)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
Apellis Pharmaceuticals (APLS)
Onestream Cl A
Take-Two Interactive Software (TTWO)
Day One Biopharmaceuticals I (DAWN)
Atrium Therapeutics (RNA)
Acuren Corporation (TIC)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals